- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Amyloidosis AA
Total 556 results
-
Florian MichelGerman Federal Ministry of Education and ResearchCompletedLight Chain (AL) Amyloidosis | Cardiac InvolvementGermany
-
Marianna FontanaRecruitingExploration of Arrhythmia Burden in Cardiac Amyloidosis Using Implantable Loop Recorders (EXACLIBUR)Sudden Cardiac Death | Arrythmia | Cardiac Amyloidosis | Systemic AL AmyloidosisUnited Kingdom
-
PfizerCompletedHereditary Transthyretin Amyloidosis (ATTRv) Cardiomyopathy (CM), Mixed PhenotypeUnited States
-
Centre Hospitalier Universitaire de NiceWithdrawnFamilial AmyloidosisFrance
-
University of Texas Southwestern Medical CenterNational Heart, Lung, and Blood Institute (NHLBI); Columbia University; The Cleveland... and other collaboratorsRecruitingAmyloidosis, Familial | Amyloidosis, Hereditary | Amyloidosis Cardiac | Transthyretin-Related (ATTR) Familial Amyloid Cardiomyopathy | Transthyretin Gene MutationUnited States
-
Alfred Chung, MDAbbVie; Janssen PharmaceuticalsRecruitingAL Amyloidosis | Light Chain (AL) Amyloidosis | Systemic Light Chain DiseaseUnited States
-
Heinrich-Heine University, DuesseldorfNot yet recruitingVirtual Reality | Amyloidosis CardiacGermany
-
Far Eastern Memorial HospitalNot yet recruiting
-
University of PennsylvaniaFox Chase Cancer CenterCompletedCardiovascular Diseases | Cancer | Hereditary Cancer | Hereditary Cardiac AmyloidosisUnited States
-
Fondazione Policlinico Universitario Agostino Gemelli...Recruiting
-
Prothena Biosciences Ltd.TerminatedPrimary Systemic (AL) AmyloidosisUnited States, Spain, Israel, Canada, Poland, Netherlands, France, Germany, United Kingdom, Belgium, Denmark, Greece, Australia, Austria, Italy
-
Fondazione Policlinico Universitario Agostino Gemelli...RecruitingHereditary Transthyretin AmyloidosisItaly
-
Alnylam PharmaceuticalsActive, not recruitingTransthyretin Amyloidosis | Amyloidosis, HereditaryUnited States, Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, Cyprus, France, Germany, Greece, Italy, Japan, Korea, Republic of, Malaysia, Mexico, Netherlands, Portugal, Spain, Sweden, Taiwan, United Kingdom
-
Nanjing University School of MedicineRecruitingLight Chain AmyloidosisChina
-
PfizerRecruitingTransthyretin Amyloidosis Cardiomyopathy (ATTR-CM)United States
-
Ramsay Générale de SantéEuropean Clinical Trial Experts NetworkRecruitingAmyloid | Systemic AmyloidosisFrance
-
The Christ HospitalThe Cleveland Clinic; Ohio State UniversityRecruitingTransthyretin AmyloidosisUnited States
-
TakedaCompletedMultiple Myeloma | Immunoglobulin Light-chain AmyloidosisSpain
-
Tufts Medical CenterCompletedMinimal Residual Disease as a Possible Predictive Factor for Relapse in Patients With AL AmyloidosisAmyloidosis | Primary AmyloidosisUnited States
-
University of EdinburghBritish Heart Foundation; Netherlands Heart Foundation; Deutsches Zentrum für...Recruiting
-
Prothena Biosciences Ltd.RecruitingLight Chain (AL) AmyloidosisUnited States, Korea, Republic of, Australia, Denmark, France, Italy, Spain, Israel, Taiwan, Austria, Canada, Czechia, Germany, Greece, Hungary, Japan, Netherlands, Poland, Portugal, Turkey, United Kingdom, Belgium, Ireland
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)TerminatedPrimary Systemic Amyloidosis | Light Chain Deposition DiseaseUnited States, Canada
-
Brigham and Women's HospitalRecruitingTransthyretin Cardiac Amyloidosis | Amyloid CardiomyopathyUnited States
-
IRCCS Policlinico S. MatteoRecruitingAL AmyloidosisGermany, Italy, Spain, Switzerland, Netherlands
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Not yet recruiting
-
Rajshekhar Chakraborty, MDGenentech, Inc.RecruitingAL AmyloidosisUnited States
-
University of Texas Southwestern Medical CenterGlaxoSmithKlineRecruitingAL Amyloidosis | AmyloidosisUnited States
-
IRCCS Policlinico S. MatteoRecruiting
-
National Cancer Institute (NCI)Recruiting
-
Emory UniversityNational Cancer Institute (NCI); SanofiRecruitingAL AmyloidosisUnited States
-
IRCCS Policlinico S. MatteoRecruiting
-
Alexion Pharmaceuticals, Inc.CompletedAL AmyloidosisUnited States
-
Memorial Sloan Kettering Cancer CenterVanderbilt University Medical Center; Tufts Medical CenterActive, not recruiting
-
Oncopeptides ABPRA Health SciencesTerminatedAL AmyloidosisSpain, United Kingdom, Germany, Norway, Israel, France, United States, Czechia, Greece
-
University Hospital, LimogesCompletedAmyloidosisFrance, Italy
-
University College, LondonCompleted
-
Boston Medical CenterCelgene CorporationCompletedAL AmyloidosisUnited States
-
Boston Medical CenterTerminatedAL AmyloidosisUnited States
-
Prothena Biosciences Ltd.CompletedPrimary AmyloidosisUnited States
-
Heidelberg UniversityGesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbHCompleted
-
University of TennesseeCompleted
-
Stanford UniversityCompletedAmyloidosis | Blood and Marrow Transplant (BMT)United States
-
Dr Jorg TaubelRichmond Pharmacology Limited; National Amyloidosis CentreNot yet recruitingCardiac AmyloidosisUnited Kingdom
-
AbbVieRecruitingImmunoglobulin Light Chain (AL) AmyloidosisJapan, United States, Australia
-
Weill Medical College of Cornell UniversityKaryopharm Therapeutics IncWithdrawnAL Amyloidosis | Amyloidosis | AmyloidUnited States
-
Stanford UniversityCelgene CorporationCompletedLeukemia | AmyloidosisUnited States
-
AstraZenecaRecruiting
-
Gérond'ifNot yet recruitingCardiac AmyloidosisFrance
-
Akcea TherapeuticsRecruitingPregnancy | Hereditary Transthyretin-mediated Amyloidosis With PolyneropathyUnited States
-
Alnylam PharmaceuticalsActive, not recruitingTransthyretin Amyloidosis (ATTR) With CardiomyopathyUnited States, Australia, Brazil, Bulgaria, France, Italy, Japan, Mexico, Netherlands, Taiwan, United Kingdom, Belgium, Czechia, Denmark, New Zealand, Sweden, Korea, Republic of, Argentina, Chile, Hong Kong, Portugal